Yongping Xie

Statistics

Publications

Citations

494

H-Index

Active since

1995

Affiliations

Genomics Institute of the Novartis Research Foundation(Current)

Harvard University

Dana-Farber Cancer Institute

Novartis (Switzerland)

Novartis Institutes for BioMedical Research

Yongping Xie is an author at Genomics Institute of the Novartis Research Foundation specializing in drug discovery, medicinal chemistry, and pharmacology.

ORCID

Publications per year

1995–2020

Publications

A General Strategy for Creating “Inactive-Conformation” Abl Inhibitors

Okram Barun, A. S. Nagle, Francisco Adrián et al. · Chemistry & Biology · 2006 · 145 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases

A. S. Nagle, Agnes Biggart, C. Be et al. · Journal of Medicinal Chemistry · 2020 · 117 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +14

A Type-II Kinase Inhibitor Capable of Inhibiting the T315I “Gatekeeper” Mutant of Bcr-Abl

Hwan Geun Choi, Pingda Ren, Francisco Adrián et al. · Journal of Medicinal Chemistry · 2010 · 73 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

Free Radical Approach to Directed Aldol-Type Reactions Promoted by Allylic O-Stannyl Ketyls

Eric J. Enholm, Yongping Xie, Khalil A. Abboud · The Journal of Organic Chemistry · 1995 · 37 citations

Natural Sciences, Chemistry, Catalysis +8

3,4,5-Trisubstituted isoxazoles as novel PPARδ agonists. Part 2

Robert Epple, Mihai Azimioara, Ross Russo et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 29 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9

1–5 of 9